Hematological Oncology

© John Wiley & Sons Ltd

Cover image for Vol. 35 Issue 2

June 2017

Volume 35, Issue 2

Pages 143–256

  1. ISSUE INFORMATION

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW
    4. ORIGINAL RESEARCH ARTICLES
    5. LETTER TO THE EDITOR
    6. CASE REPORTS
    7. BOOK REVIEW
    1. Issue Information (pages 143–144)

      Version of Record online: 16 JUN 2017 | DOI: 10.1002/hon.2356

  2. REVIEW

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW
    4. ORIGINAL RESEARCH ARTICLES
    5. LETTER TO THE EDITOR
    6. CASE REPORTS
    7. BOOK REVIEW
    1. New strategies in myelofibrosis: the evolving paradigm of disease pathogenesis, prognostication and treatment (pages 145–150)

      Francesca Palandri, Giuseppe Auteri and Michele Baccarani

      Version of Record online: 10 AUG 2016 | DOI: 10.1002/hon.2324

  3. ORIGINAL RESEARCH ARTICLES

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW
    4. ORIGINAL RESEARCH ARTICLES
    5. LETTER TO THE EDITOR
    6. CASE REPORTS
    7. BOOK REVIEW
    1. Impact on survival of addition of etoposide to primary chemotherapy in diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study (pages 151–157)

      Tove Wästerlid, Linda Hartman, Elisabeth Székely and Mats Jerkeman

      Version of Record online: 15 SEP 2015 | DOI: 10.1002/hon.2256

    2. Novel treatment for early-stage nasal natural killer/T-cell lymphoma: intra-maxillary arterial infusion chemotherapy with concomitant radiotherapy (pages 158–162)

      Miki Takahara, Toshihiro Nagato, Kan Kishibe, Seigo Ueda, Yuki Komabayashi, Masaaki Yamashina, Kouji Takahashi and Yasuaki Harabuchi

      Version of Record online: 13 NOV 2015 | DOI: 10.1002/hon.2273

    3. CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin (pages 163–171)

      Yuhei Shibata, Takeshi Hara, Senji Kasahara, Toshiki Yamada, Michio Sawada, Ryoko Mabuchi, Takuro Matsumoto, Nobuhiko Nakamura, Hiroshi Nakamura, Soranobu Ninomiya, Junichi Kitagawa, Nobuhiro Kanemura, Yusuke Kito, Naoe Goto, Tatsuhiko Miyazaki, Tsuyoshi Takami, Tamotsu Takeuchi, Masahito Shimizu and Hisashi Tsurumi

      Version of Record online: 9 OCT 2015 | DOI: 10.1002/hon.2262

    4. Human papillomavirus infection and lymphoma incidence using cervical conization as a surrogate marker: a Danish nationwide cohort study (pages 172–176)

      Suthida Intaraphet, Dóra Körmendiné Farkas, Sigrun Alba Johannesdottir Schmidt, Deirdre Cronin-Fenton and Mette Søgaard

      Version of Record online: 2 NOV 2015 | DOI: 10.1002/hon.2270

    5. Long-term safety and activity of cladribine in patients with extranodal B-cell marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT) lymphoma (pages 177–186)

      Barbara Kiesewetter, Werner Dolak, Ingrid Simonitsch-Klupp, Marius E. Mayerhoefer and Markus Raderer

      Version of Record online: 18 NOV 2015 | DOI: 10.1002/hon.2271

    6. Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling (pages 187–197)

      Thomas Menter, Michael Dickenmann, Darius Juskevicius, Juerg Steiger, Stephan Dirnhofer and Alexandar Tzankov

      Version of Record online: 22 JAN 2016 | DOI: 10.1002/hon.2280

    7. Non-Hodgkin lymphoma in Romania: a single-centre experience (pages 198–205)

      Bogdan Fetica, Patriciu Achimas-Cadariu, Bogdan Pop, Delia Dima, Ljubomir Petrov, Anamarija M. Perry, Bharat N. Nathwani, Hans K. Müller-Hermelink, Jacques Diebold, Kenneth A. MacLennan, Annamaria Fulop, Mihaiela L. Blaga, Daniela Coza, Florian Al. Nicula, Alexandru Irimie and Dennis D. Weisenburger

      Version of Record online: 20 OCT 2015 | DOI: 10.1002/hon.2266

    8. Associations between statin use and non-Hodgkin lymphoma (NHL) risk and survival: a meta-analysis (pages 206–214)

      Xibiao Ye, Ayat Mneina, James B. Johnston and Salaheddin M. Mahmud

      Version of Record online: 20 OCT 2015 | DOI: 10.1002/hon.2265

    9. Clinical characteristics of chronic lymphocytic leukemia occurring in chornobyl cleanup workers (pages 215–224)

      Stuart C. Finch, Irina Dyagil, Robert F. Reiss, Nataliya Gudzenko, Nataliya Babkina, Tatiana Lyubarets, Volodymyr Bebeshko, Anatoly Romanenko, Vadim V. Chumak, Andre Bouville, Maureen Hatch, Mark P. Little, Dimitry Bazyka and Lydia B. Zablotska

      Version of Record online: 25 JAN 2016 | DOI: 10.1002/hon.2278

    10. The importance of the number of transplanted cells with dipeptidyl peptidase-4 expression on the haematopoietic recovery and lymphocyte reconstitution in patients with multiple myeloma after autologous haematopoietic stem-cell transplantation (pages 225–231)

      Anna Kopinska, Małgorzata Krawczyk-Kulis, Joanna Dziaczkowska-Suszek, Katarzyna Bieszczad, Krystyna Jagoda and Slawomira Kyrcz-Krzemien

      Version of Record online: 2 NOV 2015 | DOI: 10.1002/hon.2267

    11. Impact of exclusion criteria for the DASISION and ENESTnd trials in the front-line treatment of a ‘real-life’ patient population with chronic myeloid leukaemia (pages 232–236)

      Roberto Latagliata, Ida Carmosino, Federico Vozella, Paola Volpicelli, Federico De Angelis, Maria Giovanna Loglisci, Adriano Salaroli, Maria Lucia De Luca, Chiara Montagna, Alessandra Serrao, Matteo Molica, Daniela Diverio, Mauro Nanni, Marco Mancini, Massimo Breccia and Giuliana Alimena

      Version of Record online: 9 DEC 2015 | DOI: 10.1002/hon.2274

    12. Major impact of an early bone marrow checkpoint (day 21) for minimal residual disease in flow cytometry in childhood acute lymphoblastic leukemia (pages 237–243)

      Marion Eveillard, Nelly Robillard, Isabelle Arnoux, Richard Garand, Fanny Rialland, Caroline Thomas, Marion Strullu, Gérard Michel, Marie C. Béné, Chantal Fossat and Marie Loosveld

      Version of Record online: 9 OCT 2015 | DOI: 10.1002/hon.2263

  4. LETTER TO THE EDITOR

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW
    4. ORIGINAL RESEARCH ARTICLES
    5. LETTER TO THE EDITOR
    6. CASE REPORTS
    7. BOOK REVIEW
    1. Limited efficacy of HLA-haploidentical peripheral blood stem cell infusion in treatment of elderly patients with acute myelogenous leukaemia (pages 244–245)

      Zuzana Sustkova, Ivana Jeziskova, Dana Dvorakova, Ondrej Horky, Lukas Semerad, Barbora Weinbergerova, Martin Culen, Jiri Mayer and Zdenek Racil

      Version of Record online: 27 AUG 2015 | DOI: 10.1002/hon.2254

  5. CASE REPORTS

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW
    4. ORIGINAL RESEARCH ARTICLES
    5. LETTER TO THE EDITOR
    6. CASE REPORTS
    7. BOOK REVIEW
    1. Safety and tolerability of pomalidomide-based regimens (pomalidomide-carfilzomib-dexamethasone with or without cyclophosphamide) in relapsed/refractory multiple myeloma and severe renal dysfunction: a case series (pages 246–251)

      Joshua Richter, Noa Biran, Narjust Duma, David H. Vesole and David Siegel

      Version of Record online: 27 MAR 2016 | DOI: 10.1002/hon.2290

    2. Bendamustine for relapsed blastic plasmacytoid dendritic cell leukaemia (pages 252–255)

      Sarah Bétrian, Sarah Guenounou, Isabelle Luquet, Cécile Demur, Anne Huynh, Loïc Ysebaert, Christian Recher and Françoise Huguet

      Version of Record online: 8 OCT 2015 | DOI: 10.1002/hon.2252

  6. BOOK REVIEW

    1. Top of page
    2. ISSUE INFORMATION
    3. REVIEW
    4. ORIGINAL RESEARCH ARTICLES
    5. LETTER TO THE EDITOR
    6. CASE REPORTS
    7. BOOK REVIEW
    1. Lecture Notes: Oncology, 3rd Edition. Mark Bower and Jonathan Waxman. Wiley-Blackwell, 2016, Ebook/Paperback, 352 pp., Prices starting from 23.80 euros (page 256)

      Francesco Bertoni

      Version of Record online: 16 JUN 2017 | DOI: 10.1002/hon.2384

SEARCH

SEARCH BY CITATION